Pulmonary/Respiratory Medicine CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
Professor Ian M. Adcock, PhD, FRSB, FBPhS, FERS
December 7, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Eric Gapud, MD, PhD / Michael E. Wechsler, MD
November 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Flavia Castelino, MD / Sonye K. Danoff, MD, PhD
November 25, 2020
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH
November 20, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
Stephen V. Liu, MD
Bhavesh Shah, RPh, BCOP
November 12, 2020
Credits: 1.00 CME
PeerView Institute
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
David R. Jones, MD
November 11, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Reducing the Burden of Influenza on Children: An Exploration of Novel and Emerging Antiviral Therapy
Jesse Papenburg, MD, MSc, FRCPC
October 8, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Differential Diagnosis of Interstitial Lung Diseases: Interpreting HRCT Accurately and Working With a Multidisciplinary Approach
August 21, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat – Contemporary Insights on Diagnosing and Managing SSc-ILD in an Evolving Treatment Landscape
Lisa H. Lancaster, MD
August 19, 2020
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Building on Progress to Further Advance Care for Patients With EGFR Mutation–Positive NSCLC: A Look at Emerging Precision Medicine Strategies Encompassing Acquired Resistance, Treatment Sequencing, and Patient Considerations
Edward Garon, MD, MS
August 10, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Finding the Path to Improved Outcomes in Uncontrolled Persistent Asthma: Applying the Latest Clinical Evidence for Treatment Success
Cedric "Jamie" Rutland, MD
July 28, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Coronavirus Disease 2019 (COVID-19): Need-to-Know Information and Practical Guidance for Healthcare Professionals on the Front Lines of Patient Care
Paul E. Sax, MD
July 24, 2020
Credits: 1.00 CME / MOC / CC / CNE / CPE
Medical Learning Institute, Inc.
It's Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Rebecca S. Heist, MD, MPH
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes for Patients With Nontuberculous Mycobacterial Lung Disease: Navigating the Complexities of Diagnosis and Management
Kevin Winthrop, MD, MPH
June 23, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 10, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.00 CME / MOC / CC / CNE
Medical Learning Institute, Inc.
Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape
Alexander Drilon, MD
April 30, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Overcoming Challenges in the Treatment of Influenza: Examining the Underuse of Antiviral Therapies and Exploring Novel Approaches
Michael G. Ison, MD, MS, FIDSA, FAST
March 26, 2020
Credits: 0.75 CME
National Jewish Health
The Evolving Landscape of Severe Asthma Management: Selecting Patients for Novel Treatment and Improving Adherence
Michael E. Wechsler, MD
March 6, 2020
Credits: 1.00 CME
Purdue University College of Pharmacy
Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches
Praveen Akuthota, MD
February 18, 2020
Medical Learning Institute, Inc.
Improving Outcomes in Uncontrolled Moderate-to-Severe Asthma: Choosing the Right Treatment for the Right Patient
Reynold A. Panettieri, Jr., MD
December 27, 2019
Medical Learning Institute, Inc.
Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy
Lorinda Chung, MD, MS
December 10, 2019
Penn State College of Medicine
Winning Strategies for Diagnosing and Managing Chronic Obstructive Pulmonary Disease
Fernando J. Martinez, MD, MS
November 29, 2019
Penn State College of Medicine
Living With Severe Asthma: Understanding the Patient Experience to Guide Therapeutic Decision-Making
Nicola A. Hanania, MD, MS
November 29, 2019
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
November 4, 2019

Pages